Breaking News Instant updates and real-time market news.

BOOT

Boot Barn

$22.06

0.09 (0.41%)

, CRON

Cronos Group

$13.03

-0.71 (-5.17%)

04:55
01/16/19
01/16
04:55
01/16/19
04:55

Piper Jaffray to hold company meetings

Piper Jaffray Hosted Company Meetings at ICR Conference 2019 will b held in Orlando on January 14-16.

BOOT

Boot Barn

$22.06

0.09 (0.41%)

CRON

Cronos Group

$13.03

-0.71 (-5.17%)

CROX

Crocs

$30.03

0.13 (0.43%)

OLLI

Ollie's Bargain Outlet

$74.87

-0.21 (-0.28%)

PLAY

Dave & Buster's

$52.02

1.18 (2.32%)

TACO

Del Taco

$10.56

-0.21 (-1.95%)

WTRH

Waitr Holdings

$11.75

0.13 (1.12%)

YETI

Yeti

$17.55

-0.56 (-3.09%)

  • 03

    Mar

BOOT Boot Barn
$22.06

0.09 (0.41%)

01/02/19
JEFF
01/02/19
NO CHANGE
JEFF
Buy Gap, sell L Brands are Jefferies' best Consumer ideas for 2019
In the Consumer space, Jefferies analyst Randal Konik says his best ideas for 2019 are buying Gap (GPS) and selling L Brands (LB). The analyst recommends using the late 2018 selloff as an opportunity to get long consumer names for 2019. His other top Buy ideas are American Eagle (AEO), Boot Barn (BOOT), Capri Holdings (CPRI), Five Below (FIVE), Foot Locker (FL), Fox Factory (FOXF), Acushnet Holdings (GOLF), Kohl's (KSS), Manchester United (MANU), Ollie's Bargain Outlet (OLLI), Tiffany (TIF), Urban Outfitters (URBN), Under Armour (UAA) and Yeti (YETI). On L Brands, Konik continues to believe Victoria's Secret "is broken," Pink "is a fad" that's sales will get cut in half, and Bath & Body Works is at a "cyclical peak with daunting compares ahead." On the flip side, the analyst thinks Gap will be one of the top S&P 500 stocks in 2019. He recommends "aggressively" buying the shares at current levels.
01/02/19
WELS
01/02/19
NO CHANGE
Target $19
WELS
Market Perform
Boot Barn price target lowered to $19 from $29 at Wells Fargo
Wells Fargo analyst Tom Nikic lowered his price target for Boot Barn to $19 from $29, while reiterating a Market Perform rating on the shares. In a research note titled "2019 Retail Outlook report," the analyst says he believes Holiday reads likely slowed post Black Friday, Multinational brands struggled relative to retailers the past several months as concerns around Europe weakness, China uncertainty, a slowdown in tourism and FX pressures are growing, e-commerce meaningfully underperformed Brick and Mortar retail in 2018 as inflated multiples have been hit hard in the face of a painful tech ''unwind'' and choppier fundamentals, 2019 is likely to be worse than 2018 for the space, and Leases are coming onto retailers' balance sheets in 2019, making for worse capital structure optics.
11/19/18
JPMS
11/19/18
NO CHANGE
Target $34
JPMS
Overweight
Boot Barn risk/reward attractive at current levels, says JPMorgan
After hosting meetings with management, JPMorgan analyst Matthew Boss sees an attractive risk/reward setup in the near-term for shares of Boot Barn. The analyst sees numbers moving higher and keeps an Overweight rating on the shares with a $34 price target. He believes Boot Barn's same-store-sales remain double-digits quarter to date and oil/gas region trends "remain firmly above" company average comps despite the 25% pullback in oil prices.
01/07/19
PIVT
01/07/19
UPGRADE
Target $24
PIVT
Buy
Boot Barn upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Mitch Kummetz upgraded Boot Barn to Buy while lowering his price target for the shares to $24 from $27. The analyst views the stock's risk/reward as favorable at current levels. While oil prices have fallen, oil and gas employment has not, Kummetz tells investors in a research note. He sees Boot Barn achieving, if not exceeding, the high end of its fiscal Q3 guidance.
CRON Cronos Group
$13.03

-0.71 (-5.17%)

12/04/18
MSCO
12/04/18
NO CHANGE
Target $63
MSCO
Equal Weight
Altria potential cannabis bet likely to come at high price, says Morgan Stanley
After Canada's Cronos Group (CRON) confirmed last night that it is in discussions with Altria (MO) regarding a potential investment, Morgan Stanley analyst Pamela Kaufman said it is not surprising that the cigarette giant is evaluating cannabis investments given the evolving regulatory landscape and the company's search for long-term growth opportunities to offset secular cigarette volume declines. An investment in cannabis could be a means to gain a foothold in the category, but would likely come at an high price given the elevated valuations in the space and limited profitability of existing companies, noted Kaufman. She maintains an Equal Weight rating and $63 price target on Altria shares.
11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
12/11/18
PIPR
12/11/18
NO CHANGE
Target $75
PIPR
Overweight
Altria could partner with Philip Morris on JUUL stake, says Piper Jaffray
Even after its $1.8B investment in Cronos Group (CRON) for a 45% ownership interest, Altria Group (MO) still has "significant" spending flexibility, Piper Jaffray analyst Michael Lavery tells investors in a research note. The company remains focused on e-vapor category leadership, suggesting it may be preparing to acquire a stake in JUUL, adds the analyst. However, Altria will likely remain committed to its investment grade debt rating, which could cause it to consider partnering with Philip Morris (PM) for a stake in JUUL, especially if a deal is done at higher valuation levels, says Lavery. The analyst believes Altria can deliver double-digit earnings growth over 2018-2020, above its long-term 7%-9% growth target, driven by pricing, tax savings, managing spending, share buybacks and falling interest expense. He keeps an Overweight rating on the shares with a $75 price target.
12/07/18
ADAM
12/07/18
NO CHANGE
ADAM
Hold
Cronos investment should drive sector valuations higher, says Canaccord
Canaccord analyst Matt Bottomley said Altria Group's (MO) agreement to make a C$2.4B strategic investment in Cronos Group (CRON) for a 45% stake equates to "a lofty 36.2 times" multiple of his 2020 EV/EBITDA valuation for the cannabis company. When taken in the context of Constellation Brands' (STZ) C$5B investment in Canopy Growth (CGC) back in August, Bottomley believes an investment of this magnitude "provides overall legitimacy to the industry as a whole" and should be a positive catalyst for the sector and drive valuations higher. He maintains a Hold rating and C$9.00 price target on Cronos shares.
CROX Crocs
$30.03

0.13 (0.43%)

01/02/19
SUSQ
01/02/19
UPGRADE
SUSQ
Positive
Crocs upgraded to Positive from Neutral at Susquehanna
01/02/19
SUSQ
01/02/19
UPGRADE
Target $31
SUSQ
Positive
Crocs upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Crocs (CROX) to Positive from Neutral. The analyst cited the recent repurchase and conversion of Blackstone's (BX) preferred stock position as it removes a substantial financial overhang from the company's capital structure and shifts more control of the business into the hands of existing and potential shareholders. In addition, the business continues to accelerate as processes and products improve and the brand gains traction, said Poser, who raised his price target to $31 from $25 on Crocs shares.
01/02/19
01/02/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bausch Health (BHC) upgraded to Overweight from Neutral at Piper Jaffray with analyst David Amsellem saying while he's been "unrelentingly negative" on the company for years, it is time to "turn the page following a closer look at the business." 2. Crocs (CROX) and Shoe Carnival (SCVL) were upgraded to Positive from Neutral at Susquehanna. 3. Stryker (SYK) upgraded to Outperform from In Line at Evercore ISI. 4. CBS (CBS) upgraded to Overweight from Equal Weight at Stephens with analyst Kyle Evans saying he believes investor sentiment is poised to improve on the name in 2019 and that the company can continue to post solid results driven by underlying unit growth and stronger pricing. 5. Sirius XM (SIRI) upgraded to Overweight from Neutral at JPMorgan with analyst Sebastiano Petti saying Sirius XM shares are attractively following the 25% pullback from the 2018 highs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/31/18
PIPR
12/31/18
NO CHANGE
Target $30
PIPR
Overweight
Piper favors Nike, Under Armour, Ulta, Crocs and Funko as 2019 brand ideas
Piper Jaffray analyst Erinn Murphy lowered her price targets across the Global Lifestyle Brands group to reflect the recent market volatility. The analyst, however, feels good about the Holiday while remaining "wary on multi-brand retailers on a longer-term basis." Murphy favors Nike (NKE), Under Armour (UAA), Ulta Beauty (ULTA), Crocs (CROX) and Funko (FNKO) as 2019 ideas. She sees Under Armour as one of the better names to own into 2019 with "what still appears to be a healthy amount of skepticism around the stock." Management's 2019 targets will ultimately prove conservative and upside should continue throughout the year, Murphy tells investors in a research note. The analyst keeps an Overweight rating on Under Armour but lowered her price target for the shares to $30 from $32. She cut targets on 15 names in the Global Lifestyle Brands space, including Underweight-rated e.l.f. Beauty (ELF) to $8 from $10, Overweight-rated G-III Apparel (GIII) to $40 from $50, Overweight-rated PVH Corp. (PVH) to $140 from $150, Overweight-rated Ulta Beauty to $295 from $320 and Overweight-rated VF Corp. (VFC) to $91 from $104.
OLLI Ollie's Bargain Outlet
$74.87

-0.21 (-0.28%)

01/11/19
SPHN
01/11/19
NO CHANGE
Target $100
SPHN
Overweight
Ollie's 'smashes expectations' with holiday results, says Stephens
After Ollie's Bargain Outlet pre-announced that its holiday period sales increased 16.6%, with a comparable store sales increase of 7.1%, Stephens analyst Rick Nelson estimated that the company's full year guidance implies Q4 same-store sales growth of 6%, which he noted was well above his prior estimate of 3%. In a note partially titled "Strong Holiday Period Smashes Expectations," Nelson said he continues to see Ollie's unique experience being insulated from internet competition and keeps a $100 price target and Overweight rating on the shares.
12/06/18
PIPR
12/06/18
NO CHANGE
Target $104
PIPR
Overweight
Ollie's Bargain Outlet shares attractive after selloff, says Piper Jaffray
Piper Jaffray analyst Peter Keith views shares of Ollie's Bargain Outlet as attractive following the post-earnings selloff. Ollie's is one of the few retailers that can potentially benefit from tariffs, as supply chain disruption could lead to over-ordering and/or cancelled orders, and the company is actively pursuing close-out opportunities in this regard, Keith tells investors in a research note. He points out the company reported "strong" Q3 results and raised its 2018 guidance. The analyst raised his price target for Ollie's to $104 from $103 and maintains an Overweight rating on the name.
12/05/18
LOOP
12/05/18
NO CHANGE
Target $80
LOOP
Hold
Loop Capital lowers Ollie's target to $80 on 'far from perfect' Q3 results
Loop Capital analyst Anthony Chukumba lowered his price target for Ollie's Bargain Outlet to $80 from $85 and reiterates a Hold rating on the shares following the company's Q3 results. The stock is "priced for near perfection" yet the Q3 report and revised fiscal 2018 outlook "were far from perfect," Chukumba tells investors in a post-earnings research note. The analyst says customer transactions declined in Q3 and that he does not find the year-over-year operating margin expansion "compelling." Further, he considers Ollie's implied Q4 comp guidance "underwhelming" given management's continued bullish commentary on its toy opportunity. Ollie's Bargain Outlet closed Tuesday down 5%, or $4.40, to $86.83 and traded down another 4% to $82.11 post the earnings report.
PLAY Dave & Buster's
$52.02

1.18 (2.32%)

01/15/19
LOOP
01/15/19
NO CHANGE
Target $65
LOOP
Buy
Loop Capital raises Dave & Buster's earnings view after updated guidance
Loop Capital analyst Lynne Collier kept the Buy rating and $65 price target on Dave & Buster's after its FY18 update and also raised its FY19 EPS view by 4c to $3.02. The analyst cites the company's return of comps to positive territory, along with the strong performance of its new stores and attractive valuation of "just" 8-times expected forward EBITDA, which is "in the bottom quartile in the industry and below peers".
12/12/18
BMOC
12/12/18
NO CHANGE
Target $62
BMOC
Outperform
Dave & Buster's price target lowered to $62 from $70 at BMO Capital
BMO Capital analyst Andrew Strelzik lowered his price target on Dave & Buster's to $62 after its mixed Q3 results, modeling a lower multiple to reflect the heightened uncertainty around the company's EBITDA growth driven by its "weaker new unit productivity". The analyst also keeps his Outperform rating and sees value in the shares coming from the company's "potential return to positive comps coupled with ability to double units".
12/12/18
LOOP
12/12/18
NO CHANGE
Target $65
LOOP
Buy
Dave & Buster's price target lowered to $65 from $70 at Loop Capital
Loop Capital analyst Lynne Collier lowered her price target on Dave & Buster's to $65 after its Q3 results, saying the in-line earnings were supported by a lower tax rate. While the analyst sees the performance of the company as "volatile", she maintains a positive view of the stock and recommends that investors Buy the weakness. Collier cites Dave & Buster's launch of 4 VR titles by the end of 2019, easier comps in the next several quarters, expected sequential improvement in food and beverage from the upgraded food quality, and low valuation relative to the industry.
12/24/18
RHCO
12/24/18
NO CHANGE
Target $69
RHCO
Buy
Dave & Buster's new Dragonfrost VR game to 'heat up' sales, says SunTrust
SunTrust analyst Jake Bartlett kept his Buy rating and $69 price target on Dave & Buster's, saying his review of the new Dragonfrost VR game which launched nation-wide last Thursday is favorable. The analyst notes that the gaming experience is "more interactive" than the current Jurassic Park game and also runs a minute longer than the 5-minute duration of Jurassic Park. Bartlett expects "positive results" from the launch, adding that the next 3 weeks are typically the company's highest volume period.
TACO Del Taco
$10.56

-0.21 (-1.95%)

10/17/18
BTIG
10/17/18
DOWNGRADE
BTIG
Neutral
Del Taco downgraded to Neutral from Buy at BTIG
10/17/18
BTIG
10/17/18
DOWNGRADE
BTIG
Neutral
Del Taco downgraded to Neutral at BTIG after FY18 guidance cut
BTIG analyst Peter Saleh downgraded Del Taco to Neutral from Buy after its Q3 results and reduced FY18 outlook yesterday evening. The analyst points to the "combination of negative traffic and rising food and labor inflation" weighing on its prospects for the coming year, adding that while he is optimistic on its promotions and delivery potential, he is also worried about customers being discouraged by the company's higher pricing.
10/17/18
10/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Infosys (INFY) downgraded to Neutral from Buy at Goldman Sachs with analyst Sumeet Jain saying yesterday's Q2 results were in-line but at the expense of "unexpectedly" higher investments. 2. Netflix (NFLX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Andy Hargreaves citing quarterly results. While the analyst maintains a favorable view of Netflix's strategic positioning, he believes improving investment efficiency or significant ancillary opportunities are needed to drive upside from current levels, and he does not anticipate either over the next year. 3. Home Depot (HD), Lowe's (LOW), KB Home (KBH), and Lennar (LEN) were downgraded to Neutral from Outperform at Credit Suisse. 4. Del Taco (TACO) downgraded to Neutral from Buy at BTIG with analyst Peter Saleh citing the "combination of negative traffic and rising food and labor inflation" weighing on its prospects for the coming year, adding that while he is optimistic on its promotions and delivery potential, he is also worried about customers being discouraged by the company's higher pricing. 5. Scorpio Bulkers (SALT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette citing the company's related party transactions and recent investment in Scorpio Tankers (STNG) for the downgrade. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/03/18
WEDB
12/03/18
NO CHANGE
WEDB
Del Taco, ObsEva added to Best Ideas List at Wedbush
Wedbush expects visibility in 2019 into Del Taco's (TACO) long-term MSD-HSD EBITDA growth algorithm to result in valuation expansion toward its regional Restaurant Brands (QSR) peers, and is adding the stock to its Best Ideas List. Reiterating an Overweight rating on the shares and also adding it to its Best Ideas List, Wedbush says ObsEva (OBSV) continues to deliver stellar clinical results from its drug candidate pipeline. The firm anticipates Linzagolix to be the third entrant in the oral gonadotropin releasing hormone receptor antagonist space, but its differentiated profile and dosing options are likely to be preferred by patients.
WTRH Waitr Holdings
$11.75

0.13 (1.12%)

12/13/18
BNCH
12/13/18
NO CHANGE
Target $18
BNCH
Buy
Waitr Holdings price target raised to $18 on Bite Squad deal at Benchmark
Benchmark analyst Daniel Kurnos said Waitr Holdings' acquisition of Bite Squad will effectively double Waitr's size and market footprint and he sees significant value creation from the deal. Kurnos, who estimates the combined entity could generate over $250M in revenue in 2019 and over $410M in 2020, keeps a Buy rating on Waitr shares and raised his price target on the stock to $18 from $16.
01/03/19
BNCH
01/03/19
NO CHANGE
BNCH
Activision, Canopy Growth among Best Ideas for first half of 2019 at Benchmark
Benchmark analysts selected their Best Ideas for the first half of 2019, naming 16 stocks, including: Activision Blizzard (ATVI), BioTelemetry (BEAT), Biofrontera (BFRA), Ctrip (CTRP), Huazhu Group (HTHT), II-VI (IIVI), Intevac (IVAC), LHC Group (LHCG), Meredith (MDP), Marvell (MRVL), NeoGenomics (NEO), Pegasystems (PEGA), Silicon Labs (SLAB), Varonis (VRNS), Canopy Growth (CGC) and Waitr Holdings (WTRH).
12/03/18
12/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Autohome (ATHM) initiated with an Outperform at Macquarie. 2. Livent (LTHM) initiated with a Buy at HSBC while Albemarle (ALB) was initiated with a Hold. 3. Career Education (CECO) initiated with an Outperform at Barrington. 4. NRC Group (NRCG) initiated with a Buy at Stifel. 5. Waitr Holdings (WTRH) initiated with a Buy at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/12/18
CHLM
12/12/18
NO CHANGE
CHLM
Waitr acquisition of Bite Squad a 'positive development,' says Craig-Hallum
Craig-Hallum analyst Alex Fuhrman reiterated a Buy rating and $20 price target on Waitr Holdings after the company announced it the acquisition of Bite Squad for $321.3M. Fuhrman believes this acquisition is a "positive development" and "strong" acquisition for Waitr, dramatically expanding the company's geographic reach, making it a meaningful national player with a presence in more than 500 cities in 22 states, while providing future cost synergies.
YETI Yeti
$17.55

-0.56 (-3.09%)

01/15/19
BARD
01/15/19
NO CHANGE
Target $23
BARD
Outperform
Fresh Pick designation removed from Yeti, Outperform rating reiterated at Baird
Baird analyst Peter Benedict closed out his Fresh Pick designation on Yeti as his associated tactical catalysts have unfolded. The analyst said he continues to see significant upside opportunity for the shares longer-term as brand awareness grows and ongoing product innovation expands. Benedict reiterated his Outperform rating and $23 price target on Yeti shares.
01/15/19
PIPR
01/15/19
NO CHANGE
Target $25
PIPR
Overweight
Piper ups Yeti target to $25, calls valuation 'very reasonable'
Piper Jaffray analyst Peter Keith views Yeti's preliminary Q4 results as strong and indicative of potential sales and margin upside the company can drive going forward. Importantly, high margin direct-to-consumer sales drove most of the upside, as Yeti appears to be leveraging its recently launched national advertising, Keith tells investors in a research note after meeting with management. He continues to view the stock's valuation as "very reasonable" given the company's "strong fundamentals." The analyst raised his price target for Yeti to $25 from $24 and reiterates an Overweight rating on the name.
01/14/19
JEFF
01/14/19
NO CHANGE
Target $35
JEFF
Buy
Yeti target raised to $35 after 'strong' Q4 at Jefferies
Yeti's preliminary Q4 results were strong, as the brand continues to gain credibility in non-core categories and mix shifts favorably to direct-to-consumer, Jefferies analyst Randal Konik tells investors in a post-earnings research note. The analyst sees "significant opportunity" for Yeti to expand its total addressable market and boosted his price target for the shares to $35 from $34. He keeps a Buy rating on the name.
01/14/19
BARD
01/14/19
NO CHANGE
Target $23
BARD
Outperform
Yeti bullish thesis reinforced by Q4 update, says Baird
Baird analyst Peter Benedict noted Yeti provided a positive Q4 update which he said reinforces his bullish thesis. The analyst believes the company is on track to be a $1B brand within the next 2-3 years as rising brand awareness, ongoing product innovation, and a broadening geographic footprint will support its growth. Benedict reiterated his Outperform rating and $23 price target on Yeti shares.

TODAY'S FREE FLY STORIES

02:50
01/22/19
01/22
02:50
01/22/19
02:50
General news
FX Update: The Dollar and Yen have traded firmer »

FX Update: The Dollar…

WOLWF

Woolworths Group

$0.00

(0.00%)

18:51
01/21/19
01/21
18:51
01/21/19
18:51
Downgrade
Woolworths Group rating change at Citi »

Woolworths Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLESY

Lendlease Group

$0.00

(0.00%)

18:48
01/21/19
01/21
18:48
01/21/19
18:48
Upgrade
Lendlease Group rating change at Citi »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFSC

Enterprise Financial

$41.41

0.99 (2.45%)

17:56
01/21/19
01/21
17:56
01/21/19
17:56
Earnings
Enterprise Financial reports Q4 EPS $1.02, consensus 95c »

Reports Q4 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

FB

Facebook

$150.01

1.77 (1.19%)

16:36
01/21/19
01/21
16:36
01/21/19
16:36
Periodicals
Facebook planning to add 1,000 jobs in Ireland by year-end, Reuters says »

Facebook will hire an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 25

    Feb

  • 03

    Mar

FB

Facebook

$150.01

1.77 (1.19%)

16:33
01/21/19
01/21
16:33
01/21/19
16:33
Periodicals
Facebook's WhatsApp limits users to five text forwards, Reuters reports »

Facebook's WhatsApp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 25

    Feb

  • 03

    Mar

ENB

Enbridge

$36.10

0.425 (1.19%)

16:28
01/21/19
01/21
16:28
01/21/19
16:28
Periodicals
Enbridge gas pipeline explosion creates fireball in Ohio, Reuters says »

An explosion of an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIN

Linde plc

$160.76

3.48 (2.21%)

16:25
01/21/19
01/21
16:25
01/21/19
16:25
Periodicals
Linde Plc to launch $6B share buyback scheme, Reuters says »

Linde Plc said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

HENKY

Henkel

$0.00

(0.00%)

16:01
01/21/19
01/21
16:01
01/21/19
16:01
Downgrade
Henkel rating change at Goldman Sachs »

Henkel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$21.58

0.34 (1.60%)

14:06
01/21/19
01/21
14:06
01/21/19
14:06
Hot Stocks
Conagra exploring alternatives for Italian-based frozen pasta business »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

13:15
01/21/19
01/21
13:15
01/21/19
13:15
General news
IMF trimmed global growth amid "no-deal" Brexit and trade war concerns »

IMF trimmed global growth…

UQM

UQM Technologies

$1.10

0.05 (4.76%)

13:05
01/21/19
01/21
13:05
01/21/19
13:05
Hot Stocks
UQM Technologies acquired by Danfoss Power Solutions for $1.71 per share »

UQM Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$41.50

-0.54 (-1.28%)

12:37
01/21/19
01/21
12:37
01/21/19
12:37
Hot Stocks
Sanofi granted U.K. marketing authorization for TIV High Dose »

U.K. marketing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

RTN

Raytheon

$165.11

2.285 (1.40%)

12:33
01/21/19
01/21
12:33
01/21/19
12:33
Hot Stocks
Raytheon awarded $24.36M order for F/A-18 aircraft system repair »

Raytheon said it was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBCP

Independent Bank

$22.80

-0.11 (-0.48%)

11:26
01/21/19
01/21
11:26
01/21/19
11:26
Hot Stocks
Independent Bank boosts quarterly dividend by 20% to 18c »

Independent Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

11:25
01/21/19
01/21
11:25
01/21/19
11:25
General news
FX Update: The dollar majors have been directionally challenged »

FX Update: The dollar…

EDIT

Editas Medicine

$26.16

-0.01 (-0.04%)

11:25
01/21/19
01/21
11:25
01/21/19
11:25
Hot Stocks
Editas Medicine announces publication of EDIT-101 data in Nature Medicine »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

, GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

11:23
01/21/19
01/21
11:23
01/21/19
11:23
Hot Stocks
France's National Data Protection Commission fines Google 50M euros »

France's National…

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

LAD

Lithia Motors

$87.13

1.57 (1.84%)

10:25
01/21/19
01/21
10:25
01/21/19
10:25
Conference/Events
Lithia Motors to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 13

    Feb

  • 14

    Mar

CYDY

CytoDyn

$0.00

(0.00%)

10:25
01/21/19
01/21
10:25
01/21/19
10:25
Conference/Events
CytoDyn participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

ABT

Abbott

$71.43

0.9 (1.28%)

09:50
01/21/19
01/21
09:50
01/21/19
09:50
Hot Stocks
Abbott announces FDA approval of TactiCath Contact Force Ablation Catheter »

Abbott announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Jan

SFUN

Fang Holdings

$1.88

-0.01 (-0.53%)

09:48
01/21/19
01/21
09:48
01/21/19
09:48
Hot Stocks
Fang announces management changes, proposed China Index spin-off »

Fang Holdings announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TS

Tenaris

$24.32

0.64 (2.70%)

09:45
01/21/19
01/21
09:45
01/21/19
09:45
Hot Stocks
Tenaris closes acquisition of 47.79% of Saudi Steel Pipe shares »

Tenaris S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$14.17

-0.31 (-2.14%)

09:42
01/21/19
01/21
09:42
01/21/19
09:42
Hot Stocks
Pan American reports 2018 silver production 24.8M ounces »

Pan American Silver Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWS

Crown Crafts

$5.68

(0.00%)

09:38
01/21/19
01/21
09:38
01/21/19
09:38
Hot Stocks
Crown Crafts announces retirement of NoJo Baby & Kids CEO »

Crown Crafts (CRWS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.